Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
According to Hong Kong Stock Exchange filings, Citigroup reduced its short position in CATL (03750.HK) H shares from 4.91% to 3.40% on June 26.
2026-07-03
According to Hong Kong Stock Exchange filings, Citigroup reduced its short position in CATL (03750.HK) H shares from 4.91% to 3.40% on June 26.
Back
Other News
2026-07-02
White House National Economic Council Director Hassett: US labor market remains on an upward trend.
White House National Economic Council Director Hassett: US labor market remains on an upward trend.
2026-07-03
UBS said after a virtual healthcare roadshow with Xinda Biologics (01801.HK) management that Q2 product sales momentum remains solid and is being treated as a new normal, supported by an innovative product mix and high unmet demand. Management said t
UBS said after a virtual healthcare roadshow with Xinda Biologics (01801.HK) management that Q2 product sales momentum remains solid and is being treated as a new normal, supported by an innovative product mix and high unmet demand. Management said tightening of online channels for GLP‑1s has not created pressure and cited healthy category demand during the recent 618 e‑commerce event. UBS has included Pfizer licensing income and sales of partner asset Abesili in its model but raised 2026–28 R&D expense forecasts to reflect collaboration commitments, trimming EPS estimates for 2026–2028 to 1.12, 2.41 and 3.42 yuan from 1.13, 2.91 and 4.41 yuan. UBS slightly raised its target price to HK$124.1 (from HK$124) and reiterated an upgrade/buy rating.
Chat with us
, powered by
LiveChat